Correlation Between Vigil Neuroscience and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Edgewise Therapeutics, you can compare the effects of market volatilities on Vigil Neuroscience and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Edgewise Therapeutics.
Diversification Opportunities for Vigil Neuroscience and Edgewise Therapeutics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Vigil and Edgewise is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Edgewise Therapeutics
Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Edgewise Therapeutics. In addition to that, Vigil Neuroscience is 1.47 times more volatile than Edgewise Therapeutics. It trades about -0.32 of its total potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 3,404 in Edgewise Therapeutics on August 28, 2024 and sell it today you would lose (206.00) from holding Edgewise Therapeutics or give up 6.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vigil Neuroscience vs. Edgewise Therapeutics
Performance |
| Timeline |
| Vigil Neuroscience |
| Edgewise Therapeutics |
Vigil Neuroscience and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vigil Neuroscience and Edgewise Therapeutics
The main advantage of trading using opposite Vigil Neuroscience and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |